Company / Working Capital
MADRIGAL PHARMACEUTICALS, INC. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$935.5M
FY2025
5-year range
$194.8M / $935.5M
FY2021-FY2025
Trend
+8.3%
vs FY2024
Sector context
#42 of 213
Health Care
What the data says
MADRIGAL PHARMACEUTICALS, INC.'s working capital of $935M is higher than 80% of companies in the Health Care sector (FY2025). Working Capital has increased for 4 consecutive years, from $195M in FY2021 to $935M in FY2025.
Based on SEC 10-K filings.
$935M in FY2025 with a 5-year CAGR of +31.4%. Top quartile in the Health Care sector.
Improved from $519M to $935M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +56.2%
- 5-Year CAGR
- +31.4%
- 10-Year CAGR
- -
Sector benchmark
In line with sector average
Key checks
Key Insights
- MADRIGAL PHARMACEUTICALS, INC.'s working capital has grown for 4 consecutive years.
- 5-year CAGR of +31.4%, indicating consistent growth.
- In FY2025, working capital increased 8.3% year-over-year.
- Ranks #42 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $935.5M | +8.3% |
| FY2024 | $863.6M | +66.5% |
| FY2023 | $518.7M | +111.3% |
| FY2022 | $245.5M | +26.0% |
| FY2021 | $194.8M | -18.3% |
| FY2020 | $238.6M | -42.5% |
| FY2019 | $415.1M | -12.9% |
| FY2018 | $476.8M | +162.0% |
| FY2017 | $182.0M | +399.8% |
| FY2016 | $36.4M | -46.8% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026